Back to News
Market Impact: 0.4

Pre-Market Earnings Report for August 13, 2025 : ESLT, PFGC, CAE, EAT, LOAR, GLBE, HBM, MRX, NYAX, SPRY, SPNS, MSGE

ESLTPFGCCAEEATLOARGLBEHBMMRXNYAXSPRYSPNSMSGENDAQ
Corporate EarningsAnalyst EstimatesCompany FundamentalsShort Interest & Activism
Pre-Market Earnings Report for August 13, 2025 :  ESLT, PFGC, CAE, EAT, LOAR, GLBE, HBM, MRX, NYAX, SPRY, SPNS, MSGE

A diverse group of companies spanning aerospace and defense, technology, food, and entertainment sectors are scheduled to report Q2 2025 earnings on August 13, 2025. Analyst consensus forecasts indicate significant year-over-year EPS growth for firms like Nayax (+225%) and Global-E Online (+115.38%), while others such as ARS Pharmaceuticals and Madison Square Garden Entertainment are projected to see substantial declines. The previews also detail historical performance against estimates and provide 2025/2026 Price-to-Earnings ratios relative to industry averages, offering critical insights into analyst growth expectations and valuation disparities ahead of the releases.

Analysis

The upcoming earnings reports for August 13, 2025, reveal a market of stark contrasts, with significant divergence in expected performance across various sectors. Standouts with exceptionally strong growth forecasts include Nayax (NYAX) and Global-E Online (GLBE), with projected year-over-year EPS increases of 225.00% and 115.38%, respectively. Both companies have a consistent history of beating analyst expectations and carry high 2025 P/E ratios (78.53 for NYAX, 117.07 for GLBE) relative to their industries, indicating that significant future growth is already priced in. Similarly, Brinker International (EAT) is expected to post a 50.93% EPS increase, though its credibility is tempered by a recent earnings miss in Q2 2024. In the aerospace and defense sector, Elbit Systems (ESLT) and Loar Holdings (LOAR) anticipate robust EPS growth of 23.56% and 23.08%, respectively, and both have a track record of beating consensus. However, their valuations differ, with ESLT's P/E of 40.01 trading below its industry average (54.20), while LOAR's P/E of 109.85 is substantially higher. Conversely, several firms face significant headwinds. ARS Pharmaceuticals (SPRY) and Madison Square Garden Entertainment (MSGE) are projected to see EPS contract by 215.38% and 144.68%, respectively. These negative outlooks are compounded by risk factors, including high short interest for SPRY (days to cover exceeds 11) and a recent earnings miss for MSGE (-27.78% in Q4 2024). Other companies showing signs of weakness or stagnation include Hudbay Minerals (HBM), with a flat EPS forecast following a -100% miss in the prior quarter, and Sapiens International (SPNS), which is expected to see a 13.89% EPS decline. Marex Group (MRX) presents a mixed picture with a slight 2.22% EPS growth forecast but a notable 142.77% increase in days to cover, signaling rising bearish sentiment.